Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
about
Current status of biomarker research in neurologyAntibody biomarkers in CNS demyelinating diseases - a long and winding roadTreatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis.Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic SensitivityImportance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.Characterization of variations in IL23A and IL23R genes: possible roles in multiple sclerosis and other neuroinflammatory demyelinating diseasesEpstein-Barr-negative MS: a true phenomenon?Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes.The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South.An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.Imaging Markers for Monitoring Disease Activity in Multiple Sclerosis.Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis.Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases.Low clinical conversion rate in clinically isolated syndrome patients - diagnostic benefit of McDonald 2010 criteria?The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.Multiple Sclerosis: Basic and Clinical.Prognostic value of free light chains lambda and kappa in early multiple sclerosis.The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS - Yes.Inflammasome Proteins As Biomarkers of Multiple Sclerosis."No evidence of disease activity" - is it an appropriate surrogate in multiple sclerosis?Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome.[Cerebrospinal fluid diagnostics in multiple sclerosis].The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.Clinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis.Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis
P2860
Q26744505-78748E60-89ED-41B7-B452-F7BD97E633EAQ28262403-F191A013-77F5-4918-9A02-FF519059B7F3Q30234672-7661FA91-230B-4BBF-8F8A-5D7E4B1EEC05Q34558843-1C554FA2-D3FB-40EB-A11F-0A38EACC14CCQ35852615-0482A127-DFA7-4D78-938F-344ADA2B68A9Q36339988-536363DC-FEAE-4164-AB1C-DB2868EFA4E3Q36599053-FF68C328-E57E-4328-A5DD-33C16D32ED73Q37047770-1E7E5E91-8D0D-4FC1-BB38-64DB2A5C869CQ37286668-E3A8837E-A387-4943-A9CD-0E698369ED4EQ37416267-E37E5788-3FB9-47A7-88E4-A94698CD39B4Q37538191-658E3061-4E5E-43F8-AFEB-97929859B6F1Q37626032-293DC657-C5B1-4639-B846-F5D41B67900DQ37721243-CFA909B1-A9DD-4FF4-8781-B07B5E103261Q38590773-F7FA9467-9903-425E-860A-00D503129B5DQ38593055-8CA46CC4-630F-4611-9A29-832FAE831FB5Q38777286-F8DAC6AA-90FF-4D13-B3AA-651B07879541Q38845037-A03D75DB-A9BC-4BF8-9232-914841AEB252Q38910574-1BC968D4-FD7B-4203-B7C0-6AC7911AAE8BQ38984981-318887CE-7BD3-4D05-B979-2C53F7F20964Q39010099-F3CF95AF-52A1-4A3C-896C-CD7D18B69B43Q39027028-32FB23E9-65EA-4716-8E60-6380222F8FCBQ39035274-C7B03F17-6E0A-43A2-8B7E-A98DC56E1540Q39247449-F0F2B01F-DF6A-43AB-90B7-8239C6D10F5DQ39460844-185A13EC-4870-49FE-802A-B26C9B256C14Q40402131-C2894C79-3403-439A-A516-C74E31E5D258Q41255081-82F02587-71B8-4211-BC01-1D7AE6D31BB6Q47105069-70953255-2386-4B7B-932A-E916977125D8Q47165920-4B5A6E98-15C0-4365-89EE-3A024265D116Q47245418-22025C3A-0705-4F8A-B05F-BF3BDDA6CA55Q47579410-DF5BAAE8-8123-421C-A09A-BBE4F9CAAFCCQ47677846-DA555B4C-065E-4760-A7F5-C6CD4E9004BCQ48412681-B0C5CAB9-DDDC-42B6-A854-30F00A13AEB7Q50068461-379D2B98-51A3-42A9-AD74-768FAB8AEABBQ52332793-798CD253-9EEF-4716-8E41-69A26C89D8F3Q52567799-FBAF0DE7-618A-46C7-904B-0C6980AF4EDBQ52803927-A7CF5B81-BAC0-4CBC-895D-0878275391CFQ52847541-325EEC4B-3AFA-4F38-9848-AB51AACC8AC6Q53317129-BB161226-E83C-43CB-BBEE-C7F55C27E2E9Q55519292-7F67872C-5F18-40D3-9EA7-F4DFE8FD733CQ56114821-2C4C1EBC-4EC7-48F5-8ED0-4CB41754FEBA
P2860
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Conversion from clinically iso ...... is: A large multicentre study.
@en
Conversion from clinically iso ...... is: A large multicentre study.
@nl
type
label
Conversion from clinically iso ...... is: A large multicentre study.
@en
Conversion from clinically iso ...... is: A large multicentre study.
@nl
prefLabel
Conversion from clinically iso ...... is: A large multicentre study.
@en
Conversion from clinically iso ...... is: A large multicentre study.
@nl
P2093
P2860
P50
P356
P1476
Conversion from clinically iso ...... sis: A large multicentre study
@en
P2093
A Altintas
A D Martínez
B C Kieseier
C Confavreux
C Enzinger
C Fenoglio
P2860
P304
P356
10.1177/1352458514568827
P50
P577
2015-02-13T00:00:00Z